Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. / Iversen, Kasper; Jensen, Annette S; Jensen, Tim V; Vejlstrup, Niels G; Søndergaard, Lars; Jensen, Annette Schophuus.

I: European Heart Journal, Bind 31, Nr. 9, 01.05.2010, s. 1124-31.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Iversen, K, Jensen, AS, Jensen, TV, Vejlstrup, NG, Søndergaard, L & Jensen, AS 2010, 'Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial', European Heart Journal, bind 31, nr. 9, s. 1124-31. https://doi.org/10.1093/eurheartj/ehq011

APA

Iversen, K., Jensen, A. S., Jensen, T. V., Vejlstrup, N. G., Søndergaard, L., & Jensen, A. S. (2010). Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. European Heart Journal, 31(9), 1124-31. https://doi.org/10.1093/eurheartj/ehq011

Vancouver

Iversen K, Jensen AS, Jensen TV, Vejlstrup NG, Søndergaard L, Jensen AS. Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. European Heart Journal. 2010 maj 1;31(9):1124-31. https://doi.org/10.1093/eurheartj/ehq011

Author

Iversen, Kasper ; Jensen, Annette S ; Jensen, Tim V ; Vejlstrup, Niels G ; Søndergaard, Lars ; Jensen, Annette Schophuus. / Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial. I: European Heart Journal. 2010 ; Bind 31, Nr. 9. s. 1124-31.

Bibtex

@article{be647b2c896641ad953572891f4dabac,
title = "Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial",
abstract = "To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.",
author = "Kasper Iversen and Jensen, {Annette S} and Jensen, {Tim V} and Vejlstrup, {Niels G} and Lars S{\o}ndergaard and Jensen, {Annette Schophuus}",
year = "2010",
month = may,
day = "1",
doi = "http://dx.doi.org/10.1093/eurheartj/ehq011",
language = "English",
volume = "31",
pages = "1124--31",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "9",

}

RIS

TY - JOUR

T1 - Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial

AU - Iversen, Kasper

AU - Jensen, Annette S

AU - Jensen, Tim V

AU - Vejlstrup, Niels G

AU - Søndergaard, Lars

AU - Jensen, Annette Schophuus

PY - 2010/5/1

Y1 - 2010/5/1

N2 - To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.

AB - To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.

U2 - http://dx.doi.org/10.1093/eurheartj/ehq011

DO - http://dx.doi.org/10.1093/eurheartj/ehq011

M3 - Journal article

VL - 31

SP - 1124

EP - 1131

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 9

ER -

ID: 34080333